Cost and cost-effectiveness of a universal HIV testing and treatment intervention in Zambia and South Africa: evidence and projections from the HPTN 071 (PopART) trial.

Thomas, Ranjeeta; Probert, William JM; Sauter, Rafael; Mwenge, Lawrence; Singh, Surya; Kanema, Sarah; Vanqa, Nosivuyile; Harper, Abigail; Burger, Ronelle; Cori, Anne; +14 more... Pickles, Michael; Bell-Mandla, Nomtha; Yang, Blia; Bwalya, Justin; Phiri, Mwelwa; Shanaube, Kwame; Floyd, Sian; Donnell, Deborah; Bock, Peter; Ayles, Helen; Fidler, Sarah; Hayes, Richard J; Fraser, Christophe; Hauck, Katharina; HPTN 071 (PopART) study team; (2021) Cost and cost-effectiveness of a universal HIV testing and treatment intervention in Zambia and South Africa: evidence and projections from the HPTN 071 (PopART) trial. The Lancet. Global health, 9 (5). e668-e680. ISSN 2214-109X DOI: https://doi.org/10.1016/S2214-109X(21)00034-6

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1016/S2214-109X(21)00034-6

Abstract

Share

Download

Restricted to: Repository staff only

Request a copy

Filename: 1-s2.0-S2214109X21000346-main.pdf

Licence: Creative Commons: Attribution-Noncommercial-No Derivative Works 3.0

[img]

Downloads

View details

Metrics & Citations


Google Scholar